Back to Search
GEOFFREY KRYSTAL, M.D.
M.D.
Medical Oncology Physician
NPI: 1245287176Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Receptor tyrosine kinase mutations: molecular indicators for therapeutic response or signposts marking important signaling pathways?
PMID 16322688·Cancer Biol Ther·2005
4-observational
Imatinib mesylate (STI571) for myeloid malignancies other than CML.
PMID 15036942·Leuk Res·2004
6-review
Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.
PMID 12481412·Mol Cancer Ther·2002
8-other
Mechanisms of resistance to imatinib (STI571) and prospects for combination with conventional chemotherapeutic agents.
PMID 11512148·Drug Resist Updat·2001
6-review
Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells.
PMID 11325836·Cancer Res·2001
7-preclinical
The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.
PMID 10955819·Clin Cancer Res·2000
8-other
Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal.
PMID 19667399·Blood·2009
7-preclinical
SHIP prevents lipopolysaccharide from triggering an antiviral response in mice.
PMID 19139077·Blood·2009
7-preclinical
Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737.
PMID 19372561·Mol Cancer Ther·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1201 BROAD ROCK BLVD, BOX 111-K
RICHMOND, VA 23249 - Phone
- (804) 675-5446
Quick Facts
- NPI
- 1245287176
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile